Esophageal cancer therapy surgery, radiation, and chemotherapy

John Holland, Christopher A. Canning

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite therapy, most patients diagnosed with esophageal cancer in 2004 will die from their disease. Surgery and radiation have been the historical treatments of choice for esophageal cancer. However, in an effort to improve outcome, combination therapies have emerged with concurrent chemoradiotherapy, neoadjuvant chemotherapy and chemoradiotherapy, and adjuvant chemotherapy and chemoradiotherapy. Strong proponents for specific individual therapeutic approaches exist, as does controversy because no optimal treatment plan for esophageal cancer has clearly emerged.

Original languageEnglish (US)
Title of host publicationEndoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management
PublisherHumana Press
Pages85-97
Number of pages13
ISBN (Print)158829532X, 9781588295323
DOIs
StatePublished - 2006

Fingerprint

Esophageal Neoplasms
Radiotherapy
Drug Therapy
Chemoradiotherapy
Adjuvant Chemoradiotherapy
Therapeutics
Adjuvant Chemotherapy
Radiation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Holland, J., & Canning, C. A. (2006). Esophageal cancer therapy surgery, radiation, and chemotherapy. In Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management (pp. 85-97). Humana Press. https://doi.org/10.1007/978-1-59745-172-7_8

Esophageal cancer therapy surgery, radiation, and chemotherapy. / Holland, John; Canning, Christopher A.

Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press, 2006. p. 85-97.

Research output: Chapter in Book/Report/Conference proceedingChapter

Holland, J & Canning, CA 2006, Esophageal cancer therapy surgery, radiation, and chemotherapy. in Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press, pp. 85-97. https://doi.org/10.1007/978-1-59745-172-7_8
Holland J, Canning CA. Esophageal cancer therapy surgery, radiation, and chemotherapy. In Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press. 2006. p. 85-97 https://doi.org/10.1007/978-1-59745-172-7_8
Holland, John ; Canning, Christopher A. / Esophageal cancer therapy surgery, radiation, and chemotherapy. Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Humana Press, 2006. pp. 85-97
@inbook{c985c9147bdc4deabb3181dfd0319f0a,
title = "Esophageal cancer therapy surgery, radiation, and chemotherapy",
abstract = "Despite therapy, most patients diagnosed with esophageal cancer in 2004 will die from their disease. Surgery and radiation have been the historical treatments of choice for esophageal cancer. However, in an effort to improve outcome, combination therapies have emerged with concurrent chemoradiotherapy, neoadjuvant chemotherapy and chemoradiotherapy, and adjuvant chemotherapy and chemoradiotherapy. Strong proponents for specific individual therapeutic approaches exist, as does controversy because no optimal treatment plan for esophageal cancer has clearly emerged.",
author = "John Holland and Canning, {Christopher A.}",
year = "2006",
doi = "10.1007/978-1-59745-172-7_8",
language = "English (US)",
isbn = "158829532X",
pages = "85--97",
booktitle = "Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management",
publisher = "Humana Press",

}

TY - CHAP

T1 - Esophageal cancer therapy surgery, radiation, and chemotherapy

AU - Holland, John

AU - Canning, Christopher A.

PY - 2006

Y1 - 2006

N2 - Despite therapy, most patients diagnosed with esophageal cancer in 2004 will die from their disease. Surgery and radiation have been the historical treatments of choice for esophageal cancer. However, in an effort to improve outcome, combination therapies have emerged with concurrent chemoradiotherapy, neoadjuvant chemotherapy and chemoradiotherapy, and adjuvant chemotherapy and chemoradiotherapy. Strong proponents for specific individual therapeutic approaches exist, as does controversy because no optimal treatment plan for esophageal cancer has clearly emerged.

AB - Despite therapy, most patients diagnosed with esophageal cancer in 2004 will die from their disease. Surgery and radiation have been the historical treatments of choice for esophageal cancer. However, in an effort to improve outcome, combination therapies have emerged with concurrent chemoradiotherapy, neoadjuvant chemotherapy and chemoradiotherapy, and adjuvant chemotherapy and chemoradiotherapy. Strong proponents for specific individual therapeutic approaches exist, as does controversy because no optimal treatment plan for esophageal cancer has clearly emerged.

UR - http://www.scopus.com/inward/record.url?scp=84891468727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891468727&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-172-7_8

DO - 10.1007/978-1-59745-172-7_8

M3 - Chapter

AN - SCOPUS:84891468727

SN - 158829532X

SN - 9781588295323

SP - 85

EP - 97

BT - Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management

PB - Humana Press

ER -